Evidence map›Paper›PMID 19127654›Full record

ArticleAmerican journal of mental retardation : AJMR2008

Autism profiles of males with fragile X syndrome.

Susan W Harris, David Hessl, Beth Goodlin-Jones, Jessica Ferranti, Susan Bacalman, Ingrid Barbato, Flora Tassone, Paul J Hagerman, Herman Herman, Randi J Hagerman

Registry-linked trialAbstract read
In one paragraph

Article in American journal of mental retardation : AJMR, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06279858 (Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome), which is not on this map. Cited by 224 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06279858 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome: Pilot Study

TypeinterventionalSponsorSpecila hospital for cerebral palsy and developmental neurologyRan2024 to 2024Enrolled15ConditionsFragile X SyndromeArmsProbiotics
3 · Its place in the literature

Who cites it

224 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. L-acetylcarnitine for treating fragile X syndrome.The Cochrane database of systematic reviews · 2015
    Pooled it
  6. Folic acid for fragile X syndrome.The Cochrane database of systematic reviews · 2011
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Prelinguistic Communication Complexity of Children With Neurogenetic Syndromes.Journal of speech, language, and hearing research : JSLHR · 2025
    Article
  18. Article
  19. Article
  20. Article

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Susan W HarrisM.I.N.D. Institute and Department of Pediatrics, University of California at Davis Medical Center, Sacramento, CA 95817, USA. randi.hagerman@ucdmc.ucdavis.edu
David Hessl
Beth Goodlin-Jones
Jessica Ferranti
Susan Bacalman
Ingrid Barbato
Flora Tassone
Paul J Hagerman
Herman Herman
Randi J Hagerman

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Autism Speaks AS1751NICHD NIH HHS HD02274NICHD NIH HHS HD036071NICHD NIH HHS P30 HD002274NICHD NIH HHS R01 HD036071
6 · The paper itself

Abstract

Autism, which is common in individuals with fragile X syndrome, is often difficult to diagnose. We compared the diagnostic classifications of two measures for autism diagnosis, the ADOS and the ADI-R, in addition to the DSM-IV-TR in 63 males with this syndrome. Overall, 30% of the subjects met criteria for autistic disorder and 30% met criteria for PDD-NOS. The classifications on the ADOS and DSM-IV-TR were most similar, whereas the ADI-R classified subjects as autistic much more frequently. We further investigated the relationship of both FMRP and FMRI mRNA to symptoms of autism in this cohort and found no significant relationship between the measures of autism and molecular features, including FMRP, FMRI mRNA, and CGG repeat number.

Indexed as

Adaptation, PsychologicalAllelesAutistic DisorderCognition DisordersDiagnostic and Statistical Manual of Mental DisordersFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansMaleNeuropsychological TestsYoung AdultFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID19127654
PMCPMC2629645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.